Zhuangwu Li
- Molecular Biology
- Oncology top 10%
- Genetics
- Biotechnology top 5%
- Cancer Research
- Co-authors
- Prem SethKenneth H. CowanDai KatayoseMin KimCaroline CraigRobert P. WerstoJane B. TrepelHuafeng Wei
- Topics
- Cancer-related Molecular Pathways (7 papers)Cancer Research and Treatments (6 papers)Virus-based gene therapy research (4 papers)
- Cited by
- BiotechnologyOncologyCancer Research
- Partner nations
- United States
In The Last Decade
Zhuangwu Li
8 papers receiving 530 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 378
- Oncology 308
- Genetics 142
- Biotechnology 133
- Cancer Research 84
Countries citing papers authored by Zhuangwu Li
This map shows the geographic impact of Zhuangwu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuangwu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuangwu Li more than expected).
Fields of papers citing papers by Zhuangwu Li
This network shows the impact of papers produced by Zhuangwu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuangwu Li. The network helps show where Zhuangwu Li may publish in the future.
Co-authorship network of co-authors of Zhuangwu Li
This figure shows the co-authorship network connecting the top 25 collaborators of Zhuangwu Li. A scholar is included among the top collaborators of Zhuangwu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhuangwu Li. Zhuangwu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 111 | |
| 3 | 48 | |
| 4 | 100 | |
| 5 | A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: a gene therapy approach for drug-resistant cancers. | 34 |
| 6 | Enzyme/prodrug gene therapy approach for breast cancer using a recombinant adenovirus expressing Escherichia coli cytosine deaminase. | 41 |
| 7 | 175 | |
| 8 | Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas. | 22 |
About Zhuangwu Li
Zhuangwu Li is a scholar working on Biotechnology, Oncology and Genetics, having authored 8 papers that have together received 550 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), Cancer Research and Treatments (6 papers) and Virus-based gene therapy research (4 papers). The work is most often cited by research in Biotechnology (133 citations), Oncology (308 citations) and Cancer Research (84 citations). Zhuangwu Li has collaborated with scholars based in United States. Frequent co-authors include Prem Seth, Kenneth H. Cowan, Dai Katayose, Min Kim, Caroline Craig, Robert P. Wersto, Jane B. Trepel, Huafeng Wei, Paul A. Saunders and De‐Maw Chuang. Their work appears in journals such as Journal of Neuroscience, Oncogene and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.